IMPRINT is a network focusing on maternal and neonatal immunisation, funded by the UK’s Global Challenges Research Fund (GCRF) and coordinated by Network Director Prof. Beate Kampmann (London School of Hygiene and Tropical Medicine) and Co-Director Dr Chrissie Jones (University of Southampton). IMPRINT aims to build a sustainable network of stakeholders from basic science, immunology, vaccinology, social science, industry, public health, and national and international policymakers to answer fundamental biological questions about antibody transfer across the placenta, how to induce the "best" antibody, and antibodies’ effect on the maturing newborn immune system.
IMPRINT has close to 300 members from 50 countries. Together, they aim to investigate if and how maternal vaccines interfere with the way babies responds to vaccines later in infancy and childhood. To ensure the optimal protection of vaccines in pregnancy and early life, IMPRINT’s members also look at how co-factors such as nutrition or other infections might change the way in which mothers and infants are protected by vaccines. To optimise the uptake of current and new vaccines, IMPRINT is also trying to find out why women decide to receive or not get vaccines in different countries. The network endeavours to work out how vaccine safety and effectiveness can be best monitored in a world where different countries health care systems function very differently. Addressing these implementation challenges will provide a better understanding of the issues and site-preparedness in the many geographical areas and populations in which IMPRINT investigators work.
Immunising Pregnant Women and Infants Network
MRC UK, GCRF, BBSRC
1 June 2017 – 31 May 2021 (48 Months)
2.5 million GBP
Prof. Beate Kampmann, LSHTM & Dr Chrissie Jones, University of Southampton